<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">35867561</PMID><DateCompleted><Year>2022</Year><Month>08</Month><Day>12</Day></DateCompleted><DateRevised><Year>2023</Year><Month>12</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1098-5514</ISSN><JournalIssue CitedMedium="Internet"><Volume>96</Volume><Issue>15</Issue><PubDate><Year>2022</Year><Month>Aug</Month><Day>10</Day></PubDate></JournalIssue><Title>Journal of virology</Title><ISOAbbreviation>J Virol</ISOAbbreviation></Journal><ArticleTitle>Mouse Scarb2 Modulates EV-A71 Pathogenicity in Neonatal Mice.</ArticleTitle><Pagination><StartPage>e0056122</StartPage><MedlinePgn>e0056122</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e00561-22</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1128/jvi.00561-22</ELocationID><Abstract><AbstractText>Enterovirus A71 (EV-A71) is a human pathogen that causes hand, foot, and mouth disease, which can progress to severe neurological disease. EV-A71 infects humans via the human scavenger receptor B2 (hSCARB2). It can also infect neonatal mice experimentally. Wild-type (WT) EV-A71 strains replicate primarily in the muscle of neonatal mice; however, susceptibility lasts only for a week after birth. Mouse-adapted (MA) strains, which can be obtained by serial passages in neonatal mice, are capable of infecting both muscle and neurons of the central nervous system. It is not clear how the host range and tropism of EV-A71 are regulated and why neonatal mice lose their susceptibility during development. We hypothesized that EV-A71 infection in neonatal mice is mediated by mouse Scarb2 (mScarb2) protein. Rhabdomyosarcoma (RD) cells expressing mScarb2 were prepared. Both WT and MA strains infected mScarb2-expressing cells, but the infection efficiency of the WT strain was much lower than that of the MA strain. Infection by WT and MA strains <i>in vivo</i> was abolished completely in <i>Scarb2</i><sup>-/-</sup> mice. <i>Scarb2</i><sup>+/-</sup> mice, in which Scarb2 expression was approximately half of that in <i>Scarb2</i><sup>+/+</sup> mice, showed a milder pathology than <i>Scarb2</i><sup>+/+</sup> mice after infection with the WT strain. The Scarb2 expression level in muscle decreased with aging, which was consistent with the reduced susceptibility of aged mice to infection. These results indicated that EV-A71 infection is mediated by mScarb2 and that the severity of the disease, the spread of virus, and the susceptibility period are modulated by mScarb2 expression. <b>IMPORTANCE</b> EV-A71 infects humans naturally but can also infect neonatal mice. The tissue tropism and severity of EV-A71 disease are determined by several factors, among which the virus receptor is thought to be important. We show that EV-A71 can infect neonatal mice using mScarb2. However, the infection efficiency of WT strains via mScarb2 is so low that an elevated virus-receptor interaction associated with mouse adaptation mutation and decrease in mScarb2 expression level during development modulate the severity of the disease, the spread of virus, and the susceptibility period in the artificial neonatal mice model.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Miwatashi</LastName><ForeName>Wakako</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Neurovirology Project, Department of Disease and Infection, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Ishida</LastName><ForeName>Minori</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Neurovirology Project, Department of Disease and Infection, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Takashino</LastName><ForeName>Ayako</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Neurovirology Project, Department of Disease and Infection, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kobayashi</LastName><ForeName>Kyousuke</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Neurovirology Project, Department of Disease and Infection, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yamaguchi</LastName><ForeName>Midori</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Laboratory for Transgenic Technology, Center for Basic Technology Research, Tokyo Metropolitan Institute of Medical Sciencegrid.272456.0, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shitara</LastName><ForeName>Hiroshi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Laboratory for Transgenic Technology, Center for Basic Technology Research, Tokyo Metropolitan Institute of Medical Sciencegrid.272456.0, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koike</LastName><ForeName>Satoshi</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-2745-5254</Identifier><AffiliationInfo><Affiliation>Neurovirology Project, Department of Disease and Infection, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>07</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Virol</MedlineTA><NlmUniqueID>0113724</NlmUniqueID><ISSNLinking>0022-538X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018955">CD36 Antigens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051907">Lysosomal Membrane Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011991">Receptors, Virus</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C489452">Scarb2 protein, mouse</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000831" MajorTopicYN="N">Animals, Newborn</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018955" MajorTopicYN="Y">CD36 Antigens</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004198" MajorTopicYN="N">Disease Susceptibility</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="Y">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006232" MajorTopicYN="N">Hand, Foot and Mouth Disease</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058507" MajorTopicYN="N">Host Specificity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051907" MajorTopicYN="Y">Lysosomal Membrane Proteins</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011991" MajorTopicYN="Y">Receptors, Virus</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D056189" MajorTopicYN="N">Viral Tropism</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014774" MajorTopicYN="N">Virulence</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">EV-A71</Keyword><Keyword MajorTopicYN="N">Scarb2</Keyword><Keyword MajorTopicYN="N">mouse adaptation</Keyword><Keyword MajorTopicYN="N">neonatal mouse model</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>7</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>8</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>7</Month><Day>22</Day><Hour>12</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>1</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35867561</ArticleId><ArticleId IdType="pmc">PMC9364792</ArticleId><ArticleId IdType="doi">10.1128/jvi.00561-22</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Racaniello V. 2013. Picornaviridae: the viruses and their replication, p 453&#x2013;489. In Knipe D, Howley PM (ed), Fields virology, 6th ed. Wolters Kluwer Health/Lippincott Williams &amp; Wilkins, Philadelphia, PA.</Citation></Reference><Reference><Citation>Pallansch M, Oberste MS, Whitton JL. 2013. Enteroviruses: polioviruses, Coxackieviruses, Echoviruses, and Newer Enteroviruses., p 490&#x2013;530. In Knipe D, Howley PM (ed), Fields virology, 6th ed. Wolters Kluwer Health/Lippincott Williams &amp; Wilkins, Philadelphia, PA.</Citation></Reference><Reference><Citation>WHO. 2011. A guide to clinical management and public health response for hand, foot and mouth disease (HFMD). https://apps.who.int/iris/handle/10665/207490.</Citation></Reference><Reference><Citation>Huang CC, Liu CC, Chang YC, Chen CY, Wang ST, Yeh TF. 1999. Neurologic complications in children with enterovirus 71 infection. N Engl J Med 341:936&#x2013;942. 10.1056/NEJM199909233411302.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199909233411302</ArticleId><ArticleId IdType="pubmed">10498488</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang LY, Huang YC, Lin TY. 1998. Fulminant neurogenic pulmonary oedema with hand, foot, and mouth disease. Lancet 352:367&#x2013;368. 10.1016/S0140-6736(98)24031-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(98)24031-1</ArticleId><ArticleId IdType="pubmed">9717926</ArticleId></ArticleIdList></Reference><Reference><Citation>Puenpa J, Wanlapakorn N, Vongpunsawad S, Poovorawan Y. 2019. The history of Enterovirus A71 outbreaks and molecular epidemiology in the Asia-Pacific region. J Biomed Sci 26:75. 10.1186/s12929-019-0573-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12929-019-0573-2</ArticleId><ArticleId IdType="pmc">PMC6798416</ArticleId><ArticleId IdType="pubmed">31627753</ArticleId></ArticleIdList></Reference><Reference><Citation>He Y, Ong KC, Gao Z, Zhao X, Anderson VM, McNutt MA, Wong KT, Lu M. 2014. Tonsillar crypt epithelium is an important extra-central nervous system site for viral replication in EV71 encephalomyelitis. Am J Pathol 184:714&#x2013;720. 10.1016/j.ajpath.2013.11.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajpath.2013.11.009</ArticleId><ArticleId IdType="pubmed">24378407</ArticleId></ArticleIdList></Reference><Reference><Citation>Ooi MH, Solomon T, Podin Y, Mohan A, Akin W, Yusuf MA, del Sel S, Kontol KM, Lai BF, Clear D, Chieng CH, Blake E, Perera D, Wong SC, Cardosa J. 2007. Evaluation of different clinical sample types in diagnosis of human enterovirus 71-associated hand-foot-and-mouth disease. J Clin Microbiol 45:1858&#x2013;1866. 10.1128/JCM.01394-06.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.01394-06</ArticleId><ArticleId IdType="pmc">PMC1933032</ArticleId><ArticleId IdType="pubmed">17446325</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamayoshi S, Yamashita Y, Li J, Hanagata N, Minowa T, Takemura T, Koike S. 2009. Scavenger receptor B2 is a cellular receptor for enterovirus 71. Nat Med 15:798&#x2013;801. 10.1038/nm.1992.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.1992</ArticleId><ArticleId IdType="pubmed">19543282</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamayoshi S, Iizuka S, Yamashita T, Minagawa H, Mizuta K, Okamoto M, Nishimura H, Sanjoh K, Katsushima N, Itagaki T, Nagai Y, Fujii K, Koike S. 2012. Human SCARB2-dependent infection by coxsackievirus A7, A14, and A16 and enterovirus 71. J Virol 86:5686&#x2013;5696. 10.1128/JVI.00020-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00020-12</ArticleId><ArticleId IdType="pmc">PMC3347270</ArticleId><ArticleId IdType="pubmed">22438546</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamayoshi S, Ohka S, Fujii K, Koike S. 2013. Functional comparison of SCARB2 and PSGL1 as receptors for enterovirus 71. J Virol 87:3335&#x2013;3347. 10.1128/JVI.02070-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02070-12</ArticleId><ArticleId IdType="pmc">PMC3592140</ArticleId><ArticleId IdType="pubmed">23302872</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujii K, Nagata N, Sato Y, Ong KC, Wong KT, Yamayoshi S, Shimanuki M, Shitara H, Taya C, Koike S. 2013. Transgenic mouse model for the study of enterovirus 71 neuropathogenesis. Proc Natl Acad Sci USA 110:14753&#x2013;14758. 10.1073/pnas.1217563110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1217563110</ArticleId><ArticleId IdType="pmc">PMC3767555</ArticleId><ArticleId IdType="pubmed">23959904</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamayoshi S, Koike S. 2011. Identification of a human SCARB2 region that is important for enterovirus 71 binding and infection. J Virol 85:4937&#x2013;4946. 10.1128/JVI.02358-10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02358-10</ArticleId><ArticleId IdType="pmc">PMC3126200</ArticleId><ArticleId IdType="pubmed">21389126</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou D, Zhao Y, Kotecha A, Fry EE, Kelly JT, Wang X, Rao Z, Rowlands DJ, Ren J, Stuart DI. 2019. Unexpected mode of engagement between enterovirus 71 and its receptor SCARB2. Nat Microbiol 4:414&#x2013;419. 10.1038/s41564-018-0319-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-018-0319-z</ArticleId><ArticleId IdType="pubmed">30531980</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi K, Koike S. 2021. Adaptation and virulence of enterovirus-A71. Viruses 13:1661. 10.3390/v13081661.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13081661</ArticleId><ArticleId IdType="pmc">PMC8402912</ArticleId><ArticleId IdType="pubmed">34452525</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang YF, Chou CT, Lei HY, Liu CC, Wang SM, Yan JJ, Su IJ, Wang JR, Yeh TM, Chen SH, Yu CK. 2004. A mouse-adapted enterovirus 71 strain causes neurological disease in mice after oral infection. J Virol 78:7916&#x2013;7924. 10.1128/JVI.78.15.7916-7924.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.78.15.7916-7924.2004</ArticleId><ArticleId IdType="pmc">PMC446098</ArticleId><ArticleId IdType="pubmed">15254164</ArticleId></ArticleIdList></Reference><Reference><Citation>Chua BH, Phuektes P, Sanders SA, Nicholls PK, McMinn PC. 2008. The molecular basis of mouse adaptation by human enterovirus 71. J Gen Virol 89:1622&#x2013;1632. 10.1099/vir.0.83676-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.83676-0</ArticleId><ArticleId IdType="pubmed">18559932</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang SW, Wang YF, Yu CK, Su IJ, Wang JR. 2012. Mutations in VP2 and VP1 capsid proteins increase infectivity and mouse lethality of enterovirus 71 by virus binding and RNA accumulation enhancement. Virology 422:132&#x2013;143. 10.1016/j.virol.2011.10.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2011.10.015</ArticleId><ArticleId IdType="pubmed">22078110</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyamura K, Nishimura Y, Abo M, Wakita T, Shimizu H. 2011. Adaptive mutations in the genomes of enterovirus 71 strains following infection of mouse cells expressing human P-selectin glycoprotein ligand-1. J Gen Virol 92:287&#x2013;291. 10.1099/vir.0.022418-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.022418-0</ArticleId><ArticleId IdType="pmc">PMC3081077</ArticleId><ArticleId IdType="pubmed">20943886</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaini Z, Phuektes P, McMinn P. 2012. A reverse genetic study of the adaptation of human enterovirus 71 to growth in Chinese hamster ovary cell cultures. Virus Res 165:151&#x2013;156. 10.1016/j.virusres.2012.02.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2012.02.009</ArticleId><ArticleId IdType="pubmed">22406130</ArticleId></ArticleIdList></Reference><Reference><Citation>Muller U, Steinhoff U, Reis LF, Hemmi S, Pavlovic J, Zinkernagel RM, Aguet M. 1994. Functional role of type I and type II interferons in antiviral defense. Science 264:1918&#x2013;1921. 10.1126/science.8009221.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.8009221</ArticleId><ArticleId IdType="pubmed">8009221</ArticleId></ArticleIdList></Reference><Reference><Citation>Khong WX, Yan B, Yeo H, Tan EL, Lee JJ, Ng JK, Chow VT, Alonso S. 2012. A non-mouse-adapted enterovirus 71 (EV71) strain exhibits neurotropism, causing neurological manifestations in a novel mouse model of EV71 infection. J Virol 86:2121&#x2013;2131. 10.1128/JVI.06103-11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.06103-11</ArticleId><ArticleId IdType="pmc">PMC3302383</ArticleId><ArticleId IdType="pubmed">22130542</ArticleId></ArticleIdList></Reference><Reference><Citation>Caine EA, Partidos CD, Santangelo JD, Osorio JE. 2013. Adaptation of enterovirus 71 to adult interferon deficient mice. PLoS One 8:e59501. 10.1371/journal.pone.0059501.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0059501</ArticleId><ArticleId IdType="pmc">PMC3602422</ArticleId><ArticleId IdType="pubmed">23527208</ArticleId></ArticleIdList></Reference><Reference><Citation>Ke X, Zhang Y, Liu Y, Miao Y, Zheng C, Luo D, Sun J, Hu Q, Xu Y, Wang H, Zheng Z. 2020. A single mutation in the VP1 gene of enterovirus 71 enhances viral binding to heparan sulfate and impairs viral pathogenicity in mice. Viruses 12:883. 10.3390/v12080883.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v12080883</ArticleId><ArticleId IdType="pmc">PMC7472116</ArticleId><ArticleId IdType="pubmed">32823486</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi K, Sudaka Y, Takashino A, Imura A, Fujii K, Koike S. 2018. Amino acid variation at VP1-145 of enterovirus 71 determines attachment receptor usage and neurovirulence in human scavenger receptor B2 transgenic mice. J Virol 92:e00681-18. 10.1128/JVI.00681-18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00681-18</ArticleId><ArticleId IdType="pmc">PMC6052303</ArticleId><ArticleId IdType="pubmed">29848584</ArticleId></ArticleIdList></Reference><Reference><Citation>Imura A, Sudaka Y, Takashino A, Tamura K, Kobayashi K, Nagata N, Nishimura H, Mizuta K, Koike S. 2020. Development of an enterovirus 71 vaccine efficacy test using human scavenger receptor B2 transgenic mice. J Virol 94:e01921-19. 10.1128/JVI.01921-19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01921-19</ArticleId><ArticleId IdType="pmc">PMC7158731</ArticleId><ArticleId IdType="pubmed">31896594</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizuta K, Tanaka S, Komabayashi K, Aoki Y, Itagaki T, Katsushima F, Katsushima Y, Yoshida H, Ito S, Matsuzaki Y, Ikeda T. 2019. Phylogenetic and antigenic analyses of coxsackievirus A6 isolates in Yamagata, Japan between 2001 and 2017. Vaccine 37:1109&#x2013;1117. 10.1016/j.vaccine.2018.12.065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2018.12.065</ArticleId><ArticleId IdType="pubmed">30683510</ArticleId></ArticleIdList></Reference><Reference><Citation>Staring J, van den Hengel LG, Raaben M, Blomen VA, Carette JE, Brummelkamp TR. 2018. KREMEN1 is a host entry receptor for a major group of enteroviruses. Cell Host Microbe 23:636&#x2013;643.e5. 10.1016/j.chom.2018.03.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2018.03.019</ArticleId><ArticleId IdType="pubmed">29681460</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu ST, Kobayashi K, Bi X, Ishizaki A, Tran TT, Phung TTB, Pham CTT, Nguyen LV, Ta TA, Khu DTK, Agoh M, Pham AN, Koike S, Ichimura H. 2020. Newly emerged enterovirus-A71 C4 sublineage may be more virulent than B5 in the 2015-2016 hand-foot-and-mouth disease outbreak in northern Vietnam. Sci Rep 10:159. 10.1038/s41598-019-56703-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-56703-5</ArticleId><ArticleId IdType="pmc">PMC6957505</ArticleId><ArticleId IdType="pubmed">31932599</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi K, Nishimura H, Mizuta K, Nishizawa T, Chu ST, Ichimura H, Koike S. 2021. Virulence of enterovirus A71 fluctuates depending on the phylogenetic clade formed in the epidemic year and epidemic region. J Virol 95:e0151521. 10.1128/JVI.01515-21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01515-21</ArticleId><ArticleId IdType="pmc">PMC8577370</ArticleId><ArticleId IdType="pubmed">34523967</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez A, Valeiras M, Sidransky E, Tayebi N. 2014. Lysosomal integral membrane protein-2: a new player in lysosome-related pathology. Mol Genet Metab 111:84&#x2013;91. 10.1016/j.ymgme.2013.12.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ymgme.2013.12.005</ArticleId><ArticleId IdType="pmc">PMC3924958</ArticleId><ArticleId IdType="pubmed">24389070</ArticleId></ArticleIdList></Reference><Reference><Citation>Blanz J, Groth J, Zachos C, Wehling C, Saftig P, Schwake M. 2010. Disease-causing mutations within the lysosomal integral membrane protein type 2 (LIMP-2) reveal the nature of binding to its ligand beta-glucocerebrosidase. Hum Mol Genet 19:563&#x2013;572. 10.1093/hmg/ddp523.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddp523</ArticleId><ArticleId IdType="pubmed">19933215</ArticleId></ArticleIdList></Reference><Reference><Citation>Hopfner F, Schormair B, Knauf F, Berthele A, Tolle TR, Baron R, Maier C, Treede RD, Binder A, Sommer C, Maihofner C, Kunz W, Zimprich F, Heemann U, Pfeufer A, Nabauer M, Kaab S, Nowak B, Gieger C, Lichtner P, Trenkwalder C, Oexle K, Winkelmann J. 2011. Novel SCARB2 mutation in action myoclonus-renal failure syndrome and evaluation of SCARB2 mutations in isolated AMRF features. BMC Neurol 11:134. 10.1186/1471-2377-11-134.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2377-11-134</ArticleId><ArticleId IdType="pmc">PMC3222607</ArticleId><ArticleId IdType="pubmed">22032306</ArticleId></ArticleIdList></Reference><Reference><Citation>Gamp AC, Tanaka Y, Lullmann-Rauch R, Wittke D, D'Hooge R, De Deyn PP, Moser T, Maier H, Hartmann D, Reiss K, Illert AL, von Figura K, Saftig P. 2003. LIMP-2/LGP85 deficiency causes ureteric pelvic junction obstruction, deafness and peripheral neuropathy in mice. Hum Mol Genet 12:631&#x2013;646. 10.1093/hmg/ddg062.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddg062</ArticleId><ArticleId IdType="pubmed">12620969</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi K, Mizuta K, Koike S. 2020. Heparan sulfate attachment receptor is a major selection factor for attenuated enterovirus 71 mutants during cell culture adaptation. PLoS Pathog 16:e1008428. 10.1371/journal.ppat.1008428.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1008428</ArticleId><ArticleId IdType="pmc">PMC7105141</ArticleId><ArticleId IdType="pubmed">32187235</ArticleId></ArticleIdList></Reference><Reference><Citation>Jonsson N, Gullberg M, Israelsson S, Lindberg AM. 2009. A rapid and efficient method for studies of virus interaction at the host cell surface using enteroviruses and real-time PCR. Virol J 6:217. 10.1186/1743-422X-6-217.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-6-217</ArticleId><ArticleId IdType="pmc">PMC2797521</ArticleId><ArticleId IdType="pubmed">19968865</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Yang H, Shivalila CS, Dawlaty MM, Cheng AW, Zhang F, Jaenisch R. 2013. One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering. Cell 153:910&#x2013;918. 10.1016/j.cell.2013.04.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2013.04.025</ArticleId><ArticleId IdType="pmc">PMC3969854</ArticleId><ArticleId IdType="pubmed">23643243</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang H, Wang H, Shivalila CS, Cheng AW, Shi L, Jaenisch R. 2013. One-step generation of mice carrying reporter and conditional alleles by CRISPR/Cas-mediated genome engineering. Cell 154:1370&#x2013;1379. 10.1016/j.cell.2013.08.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2013.08.022</ArticleId><ArticleId IdType="pmc">PMC3961003</ArticleId><ArticleId IdType="pubmed">23992847</ArticleId></ArticleIdList></Reference><Reference><Citation>Aida T, Chiyo K, Usami T, Ishikubo H, Imahashi R, Wada Y, Tanaka KF, Sakuma T, Yamamoto T, Tanaka K. 2015. Cloning-free CRISPR/Cas system facilitates functional cassette knock-in in mice. Genome Biol 16:87. 10.1186/s13059-015-0653-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13059-015-0653-x</ArticleId><ArticleId IdType="pmc">PMC4414275</ArticleId><ArticleId IdType="pubmed">25924609</ArticleId></ArticleIdList></Reference><Reference><Citation>Hwang WY, Fu Y, Reyon D, Maeder ML, Tsai SQ, Sander JD, Peterson RT, Yeh JR, Joung JK. 2013. Efficient genome editing in zebrafish using a CRISPR-Cas system. Nat Biotechnol 31:227&#x2013;229. 10.1038/nbt.2501.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.2501</ArticleId><ArticleId IdType="pmc">PMC3686313</ArticleId><ArticleId IdType="pubmed">23360964</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaneko T, Sakuma T, Yamamoto T, Mashimo T. 2014. Simple knockout by electroporation of engineered endonucleases into intact rat embryos. Sci Rep 4:6382. 10.1038/srep06382.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep06382</ArticleId><ArticleId IdType="pmc">PMC4180828</ArticleId><ArticleId IdType="pubmed">25269785</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>